MYTELASE 10 MG TBL NOB 50
Rychlý přehled
| Dosage form | Tablets uncoated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, zkontrolujte ale specializaci předepisujícího lékaře níže. Maximální doplatek: 442,46 Kč. Maximální cena: 570,86 Kč. |
| Kdo může předepsat | neurology, pediatric neurology |
| Složení | Ambenonium-chlorid (10 mg), monohydrát laktosy, kukuřičný škrob, dihydrát hydrogenfosforečnanu vápenatého, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 19. 9. 2023. Výroba byla ukončena s platností od 6. 9. 2023. The manufacturer lists medicines with the following code as a potential substitute: 0276885 |
| Kód SÚKL | 0020327 |
What is the maximum co-payment for MYTELASE?
If the insurance company contributes, the maximum co-payment is 442,46 Kč. The maximum pharmacy price is 570,86 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but check the specialization of the prescribing physician below.
Does MYTELASE have a counted co-payment set?
Yes, the medicine has a counted co-payment of 442,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
128,40 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe MYTELASE?
- neurology, pediatric neurology
What is the composition of MYTELASE?
Ambenonium-chlorid (10 mg), monohydrát laktosy, kukuřičný škrob, dihydrát hydrogenfosforečnanu vápenatého, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found
Which medicines are similar to MYTELASE?
The medicine belongs to ATC group N07AA30 – Ambenonium. Medicines with the same active substance can be found here.
Who manufactures MYTELASE?
sanofi-aventis, s.r.o., Praha (CZ)
Is the medicine in shortage?
The latest report from the manufacturer is from 19. 9. 2023. Production was terminated with effect from 6. 9. 2023. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for MYTELASE?
The medicine has code 0020327. Code details can be found here.
How many packs of MYTELASE were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of MYTELASE were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026